Northpointe Bancshares, Inc. (NPB)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	498	-	-	-
Debt / Equity Ratio	2.16	2.82	3.06	2.35
Debt / FCF Ratio	-	69.53	2.63	0.73
Return on Equity (ROE)	-	12.35%	7.96%	-
Return on Assets (ROA)	-	1.10%	0.74%	-
Payout Ratio	2.48%	20.99%	36.20%	74.92%
Buyback Yield / Dilution	-14.29%	-0.10%	0.51%	-

Updated Jul 22, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q